Roth Capital Partners is acting as manager.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech Faces Nasdaq Non-Compliance Notice
- Moleculin Biotech’s Earnings Call: Trials and Triumphs
- Moleculin Biotech’s Growth Potential Highlighted by Phase 3 MIRACLE Trial and Strategic Advancements
- Moleculin Biotech Reports Q1 2025 Financial Results
- Moleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year